Conversely, inhibiting CTLA-4 using antibodies or the dual inhibition of CTLA-4 and PD-1 accelerates atherosclerosis with increased T-cell-driven endothelial inflammation and plaque area. This evidence concerns the gene PDCD1 and atherosclerosis.